The Return of Old Antibiotics: Are Colistin and Fosfomycin Making a Comeback?

The Return of Old Antibiotics: Are Colistin and Fosfomycin Making a Comeback? Review Abstract The rise of multidrug-resistant bacterial infections has forced clinicians to reconsider older antimicrobial agents previously abandoned due to toxicity concerns. Colistin and fosfomycin, antibiotics discovered decades ago, have experienced renewed clinical

Oral Insulin Breakthroughs In Development

Oral Insulin Breakthroughs In Development INTRODUCTION Diabetes is a chronic metabolic disorder primarily classified into two types: type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). T1DM, an autoimmune disease often diagnosed in adolescence, is marked by the body's inability to produce insulin. In contrast, T2DM, which constitutes the majority

The Return of Old Antibiotics: Are Colistin and Fosfomycin Making a Comeback?